Found: 92
Select item for more details and to access through your institution.
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 2, p. 259, doi. 10.1093/cid/ciad576
- By:
- Publication type:
- Article
The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S279, doi. 10.1093/cid/ciad475
- By:
- Publication type:
- Article
Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S288, doi. 10.1093/cid/ciad529
- By:
- Publication type:
- Article
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S295, doi. 10.1093/cid/ciad565
- By:
- Publication type:
- Article
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S305, doi. 10.1093/cid/ciad547
- By:
- Publication type:
- Article
Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S314, doi. 10.1093/cid/ciad541
- By:
- Publication type:
- Article
The Future Ain't What It Used to Be...Out With the Old...In With the Better: Antibacterial Resistance Leadership Group Innovations.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S321, doi. 10.1093/cid/ciad538
- By:
- Publication type:
- Article
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e1157, doi. 10.1093/cid/ciac692
- By:
- Publication type:
- Article
Weighing evidence: robustness vs quantity.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 1, p. 1, doi. 10.1093/jnci/djac186
- By:
- Publication type:
- Article
Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial.
- Published in:
- Trials, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13063-022-07047-5
- By:
- Publication type:
- Article
Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 6, p. 1, doi. 10.1093/ofid/ofac140
- By:
- Publication type:
- Article
Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT) Reveals Improvements in the Treatment of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae in Patients from the Veterans Health Administration
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 7, p. 1231, doi. 10.1093/cid/ciab384
- By:
- Publication type:
- Article
Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 9, p. 1091, doi. 10.1001/jamaneurol.2021.2440
- By:
- Publication type:
- Article
Antibacterial Resistance Leadership Group 2.0: Back to Business.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 4, p. 730, doi. 10.1093/cid/ciab141
- By:
- Publication type:
- Article
Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT): A Framework for Assessing Antibiotic Selection Strategies in the Presence of Drug Resistance.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 2, p. 344, doi. 10.1093/cid/ciaa1769
- By:
- Publication type:
- Article
Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 2, p. 177, doi. 10.1001/jamaneurol.2020.4396
- By:
- Publication type:
- Article
Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial.
- Published in:
- Clinical Trials, 2020, v. 17, n. 6, p. 617, doi. 10.1177/1740774520941441
- By:
- Publication type:
- Article
Simultaneous Evaluation of Diagnostic Assays for Pharyngeal and Rectal Neisseria gonorrhoeae and Chlamydia trachomatis Using a Master Protocol.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 9, p. 2314, doi. 10.1093/cid/ciz1105
- By:
- Publication type:
- Article
Acinetobacter Infections.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 5, p. 1357, doi. 10.1093/cid/ciz1099
- By:
- Publication type:
- Article
Modern Clinician-initiated Clinical Trials to Determine Optimal Therapy for Multidrug-resistant Gram-negative Infections.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 2, p. 433, doi. 10.1093/cid/ciz1132
- By:
- Publication type:
- Article
Average Weighted Accuracy: Pragmatic Analysis for a Rapid Diagnostics in Categorizing Acute Lung Infections (RADICAL) Study.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 12, p. 2736, doi. 10.1093/cid/ciz437
- By:
- Publication type:
- Article
Antibiotic Stewardship in the Intensive Care Unit. An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 4, p. 698, doi. 10.1093/cid/ciz784
- By:
- Publication type:
- Article
Presenting Risks and Benefits: Helping the Data Monitoring Committee Do Its Job.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial.
- Published in:
- International Journal of Stroke, 2019, v. 14, n. 9, p. 908, doi. 10.1177/1747493019851282
- By:
- Publication type:
- Article
Reply to Humphrey and Spafford.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
151. Comparing the Clinical Utility of Rapid Diagnostic Tests for Gram-Negative Bloodstream Infection Using a Desirability of Outcomes Ranking.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S102, doi. 10.1093/ofid/ofz360.226
- By:
- Publication type:
- Article
2168. Comparison of Rapid Diagnostic Tests for Bloodstream Infections Using Desirability of Outcome Ranking Management of Antimicrobial Therapy (DOOR-MAT).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S735, doi. 10.1093/ofid/ofz360.1848
- By:
- Publication type:
- Article
The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design.
- Published in:
- International Journal of Stroke, 2019, v. 14, n. 7, p. 745, doi. 10.1177/1747493019830307
- By:
- Publication type:
- Article
Corrigendum to: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided by Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused by Escherichia coli and Klebsiella pneumonia
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 7, p. N.PAG, doi. 10.1093/ofid/ofz267
- By:
- Publication type:
- Article
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa : PRIMERS IV.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 11, p. 1823, doi. 10.1093/cid/ciy801
- By:
- Publication type:
- Article
Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS).
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 11, p. 1961, doi. 10.1093/cid/ciy912
- By:
- Publication type:
- Article
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 10, p. 1691, doi. 10.1093/cid/ciy766
- By:
- Publication type:
- Article
Impact of Implementing Antibiotic Stewardship Programs in 15 Small Hospitals: A Cluster-Randomized Intervention.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 4, p. 525, doi. 10.1093/cid/ciy155
- By:
- Publication type:
- Article
Predicting readmission risk shortly after admission for CABG surgery.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Novel Method Suggests Global Superiority of Short-Duration Antibiotics for Intra-abdominal Infections.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 9, p. 1577, doi. 10.1093/cid/cix569
- By:
- Publication type:
- Article
A Roundtable Discussion: Advances in Patient Monitoring Translate to Improved Outcomes at the Bedside.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Interim evaluation of efficacy or futility in group-sequential trials with multiple co-primary endpoints.
- Published in:
- Biometrical Journal, 2017, v. 59, n. 4, p. 703, doi. 10.1002/bimj.201600026
- By:
- Publication type:
- Article
Sizing clinical trials when comparing bivariate time-to-event outcomes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, p. S3, doi. 10.1093/cid/ciw824
- By:
- Publication type:
- Article
Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, p. S13, doi. 10.1093/cid/ciw826
- By:
- Publication type:
- Article
Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, p. S18, doi. 10.1093/cid/ciw827
- By:
- Publication type:
- Article
The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, p. S36, doi. 10.1093/cid/ciw830
- By:
- Publication type:
- Article
Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, p. S41, doi. 10.1093/cid/ciw831
- By:
- Publication type:
- Article
Evaluating Anti-infective Drugs in the Resistant Pathogen Setting: Can We Use External Controls?
- Published in:
- Statistical Communications in Infectious Diseases, 2017, v. 9, n. 1, p. -1, doi. 10.1515/scid-2016-0003
- By:
- Publication type:
- Article
Antibiotic Use in Small Community Hospitals.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 10, p. 1273, doi. 10.1093/cid/ciw588
- By:
- Publication type:
- Article
Benefit-risk Evaluation for Diagnostics: A Framework (BED-FRAME).
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 6, p. 812, doi. 10.1093/cid/ciw329
- By:
- Publication type:
- Article
Automated identification and predictive tools to help identify high-risk heart failure patients: pilot evaluation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Corrigendum: A logrank test-based method for sizing clinical trials with two co-primary time-to-event endpoints (10.1093/biostatistics/kxs057).
- Published in:
- 2016
- By:
- Publication type:
- journal article